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Abstract
Background: Liposuction can remove a substantial amount of body fat. We investigated the effects of liposuction of large volumes of fat on anthropometrics,
body composition (BIA), metabolic hormones, and psychological measures in
overweight/obese women. To our knowledge, this is the first study to examine both
physiological and psychological changes following liposuction of large volumes
of fat in humans.
Method: Nine premenopausal healthy overweight/obese women (age = 35.9 ±
7.1 SD, weight = 84.4 kg ± 13.6, BMI = 29.9 kg/m2 ± 2.9) underwent liposuction,
removing 3.92 kg ± 1.04 SD of fat. Following an overnight fast, height, weight,
waist, and hip circumferences were measured at baseline (one week pre-surgery)
and post-surgery (wk 1,4,12). Blood samples were drawn for fasting concentrations of glucose, insulin, leptin, and ghrelin. The Body Shape Questionnaire
(BSQ), Body Dysmorphic Disorder (BDD) Examination Self-Report (BDDE-SR),
and Zung Self-Rating Depression Scale (ZDS) were administered.
Results: Body weight, BMI, waist circumference, and body fat consistently decreased over time (p < .05). Glucose did not change significantly, but insulin decreased from wk 1 to wk 12 (p < .05). Leptin decreased from baseline to wk 1 (p
= .01); ghrelin increased but not significantly. Changes in body fat and waist circumference (baseline to wk 1) correlated positively with changes in insulin during
that period, and correlated inversely with changes in ghrelin (p < .05). BSQ scores
decreased significantly over time (p = .004), but scores for BDDE-SR (p = .10)
and ZDS (p = .24) did not change significantly.
Conclusion: Liposuction led to significant decreases in body weight and fat, waist
circumference, and leptin levels. Changes in body fat and waist circumference
correlated with concurrent changes in the adipose-related hormones, insulin and
ghrelin (baseline to wk 1), and body shape perception improved. Thus, besides the
obvious cosmetic effects, liposuction led to several positive body composition,
hormonal, and psychological changes.
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Introduction
Obesity has become an epidemic in the United States and is associated with various comorbidities, such as cardiovascular
disease and insulin resistance[1]. Although more closely associated with visceral adipose tissue (VAT), insulin resistance is also correlated with subcutaneous adipose tissue (SAT)[2,3]. Despite availability of a variety of weight-loss techniques, including exercise,
diet, and behavioral therapy, such lifestyle modifications remain a challenge for many, and most individuals regain much of the lost
weight over time[4]. An alternative to diet-induced weight loss is bariatric surgery, which can lead to marked sustained reductions
in body weight and fat. However, it is restricted to clinically severe obese individuals (BMI ≥ 40 without associated comorbidity or
BMI ≥ 35 with comorbidity). Another surgical option is to undergo liposuction, which is defined by The American Society of Plastic
Copyrights: © 2015 Geliebter, A. This is an Open access article distributed under the terms of Creative Commons
Attribution 4.0 International License.
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Surgeons as a procedure that removes excess fat deposits and
improves the body contours and proportions[5], which may also
yield some potential metabolic benefits.
Results from previous literature have, however, been
inconsistent about metabolic changes following liposuction.
Giese et al. found that liposuction of large volumes of fat led to
a reduction in fasting plasma insulin and systolic blood pressure,
along with decreases in body weight and fat mass, but without
changes in fasting glucose, leptin, lipid profiles, or resting energy expenditure[6]. Two other studies found that liposuction of
large volumes of fat decreased insulin resistance[7,8], glucose,
and cholesterol[8]. A fourth study, however, failed to show that
liposuction significantly altered plasma glucose, insulin, insulin
resistance, blood pressure, or lipid concentrations despite a 44%
decrease of subcutaneous abdominal adipose tissue by volume[9].
The hormone leptin is secreted by adipose tissue, and
thus plasma levels are elevated in obese individuals, but these
individuals tend to be leptin resistant and do not benefit from
leptin’s ability to suppress appetite[10]. On the other hand, levels
of the orexigenic hormone ghrelin, associated with meal initiation and hunger, are lower in obesity[11-14]. Fasting ghrelin usually increases after diet-induced weight loss, but tends to decrease
after gastric bypass surgery, which may be a contributing factor
to reduced appetite post-surgery[15]. In obese male Zucker rats,
ghrelin decreased following liposuction[16], similar to decreased
ghrelin levels after gastric bypass surgery[17]. However, in humans, it has been observed that ghrelin levels generally increase
when body fat decreases[15].
Following weight loss, there is a homeostatic drive to
restore the lost weight[18], which can be accompanied by behavioral and psychological changes19,20]. Weight reduction has sometimes been associated with an increase in depressed mood and
preoccupation with body weight, food, and hunger[21]. Among
those successful at maintaining weight loss, however, psychological scores of depression and psychological distress generally have not increased[22]. Such psychological changes have
not been investigated in individuals undergoing liposuction of
large volumes of fat. In studies following other forms of cosmetic surgery, depression levels did not change post surgery[23,24].
About 3-15% of those seeking cosmetic surgery present with
mild to severe Body Dysmorphic Disorder (BDD)[25-28], a negative obsession with a part of the body. Cosmetic surgery did
not improve BDD based on clinical interviews[29] or BDD questionnaire scores[30], and did not help prevent the development of
BDD in those with mild or sub-threshold BDD[31]. These studies,
however, did not examine the effects of liposuction on BDD[30].
BDD has been shown to be overrepresented in those seeking
liposuction[32], suggesting a need to assess BDD following liposuction of large volumes of fat.
Body shape dissatisfaction is generally greater in
obese than lean women but can also serve as a motivator for
weight loss[33,34]. Interventions to reduce body weight, including
bariatric surgery, improved body image in the overweight and
obese[33-39]. Furthermore, there is some evidence that body image
improves following obesity treatment, independent of the degree
of weight loss[40,41].
Although there are studies on the psychological effects
of weight loss and cosmetic surgery, there are none examining
the psychological effects of the removal of large volumes of fat
in overweight and obese individuals. In the present study, we exwww.ommegaonline.org
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amined changes in both physiological and psychological aspects
following liposuction of large volumes of fat in overweight and
obese women who had approximately 4 kg of subcutaneous fat
tissue removed. To our knowledge, this is also the first study
to measure ghrelin levels in humans following liposuction. We
hypothesized that glucose, insulin, and leptin levels would decrease and ghrelin levels would increase following liposuction.
We also expected that scores of depression, body dysmorphic
disorder, and body shape dissatisfaction would improve.

Materials and Methods
Subjects
Nine obese and overweight women (BMI = 29.9 ±
2.9 SD) underwent liposuction removing a large volume of fat
(Table-1). Four participants had more than four liters (L) of fat
removed, considered large volume liposuction (LVL), four participants had just under 4L of fat removed and one participant
had 2.3 L removed, with a range of fat aspirate of 2.3 - 5.9L.
All women were premenopausal, and were not pregnant or using
birth control. They had no history of cardiac, renal, gastrointestinal or endocrine disease, including diabetes. Patients were
recruited by the surgeon (SG) over a seven-month period from
the regular pool of patients visiting the office and signed an approved IRB consent form. Their racial and ethnic distribution,
based on self-report, was 22% white, 22% Hispanic, 44% black,
and 11% other. Patients were not requested to change their eating or exercise habits prior to or after surgery.
Table 1: Preoperative Anthropometric Measures in Nine Overweight Women
Measure
Range
Mean ± SD
Age (y)
23 - 46
35.9 ± 7.1
Preoperative Weight (kg) 66.9 - 110.5
84.3 ± 29.0
Height (m)
1.6 - 1.8
1.7 ± 0.1
Body Mass Index (kg/m²) 26.7 - 36.0
29.9 ± 2.9
Waist Circumference (cm) 86.0 - 112.0
95.6 ± 9.2
Hip Circumference (cm)
96.0 - 132.0
109.3 ± 11.5
Liposuction: All patients underwent subcutaneous adipose tissue (SAT) liposuction of the abdomen. A super wet technique
was used, with small volumes of fluid injected into the fatty deposits prior to surgery to facilitate fat removal. In order to prevent excessive bleeding, dilute lidocaine and epinephrine were
injected into the SAT. Several patients additionally had small
amounts of SAT removed from their backs, flanks, arms, inner
and outer thighs for additional cosmetic benefits. An internal ultrasound-assisted liposuction system with a 4-mm hollow bullet-tip probe was used. This was followed by suction, using a
Mercedes cannula with a diameter of 4 mm and a length of 15
mm, containing three lateral suction holes. The volume of fat
aspirate was measured by collecting the aspirate in a container
during suction, and allowing the fat to rise to the top and weighed
30 min later which yielded 4358 cc ± 1155 SD. Following surgery, patients were dressed in special compression garments. No
post-surgical adverse effects were reported and inflammation
was absent by 12 weeks.
J Diabetes Obes
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Materials

Results

Patients were tested at baseline (1 week prior to surgery), and at wk 1, wk 4, and wk 12 following surgery. Fasting
blood samples were collected at each visit to measure plasma
insulin, glucose, leptin, and ghrelin. Blood samples were centrifuged, and plasma separated and stored in microtubes at -80 °C
until analyzed. Glucose was assayed with a Beckman glucose
analyzer (glucose oxidase method), insulin with a radioimmunoassay (RIA) kit from Linco (intra-assay CV = 5.5, inter-assay
CV = 4.9), leptin with an RIA kit from Linco (intra-assay CV =
4.8, inter-assay CV = 5.9), and total ghrelin (acylated and desacylated) was assayed with an (RIA) from Phoenix Pharmaceuticals (intra-assay CV = 5.2, inter-assay = 6.2). Insulin resistance
was estimated with the homeostasis model assessment (HOMA)
from fasting glucose and insulin concentrations: fasting insulin
(μU/ml) x fasting glucose (mg/dL)/405. Patients completed the
Body Shape Questionnaire (BSQ)[42], a measure of weight and
shape concern and dissatisfaction. They also completed the Body
Dysmorphic Diagnostic Examination Self-Report (BDDE-SR),
a questionnaire that assesses the degree of Body Dysmorphic
Disorder (BDD)[43] based on obsession with a specific, most distressing body part. Finally, they completed the Zung Self-Rating
Depression Scale (ZDS)[45], selected due to its advantages of reverse scoring and assessment of suicidal ideation.

Anthropometric measurements
Body weight decreased significantly between all time
points (F3,24 = 20.2, p < .001; post hoc, all p’s < .03). From baseline to wk 12, patients had a mean weight reduction of 4.7 ± 2.8
kg (Figure 1a). BMI decreased significantly (F3,24 = 4.3, p = .02)
from baseline to wk 1, baseline to wk 4, and wk 1 to wk 4 (post
hoc, p = .03, .001, and .003, respectively), and from baseline to
wk 12 (p = .06, trend). Body fat decreased significantly (F3,24
= 13.0, p < .001) from baseline to wk 1, baseline to wk 4, and
baseline to wk 12 (post hoc, p = .01, .01, and .003, respectively).
Waist circumference decreased significantly over all time points
(F3,24 = 44.5, p < .001; post hoc all p’s < .03). All the data above
are shown in Figure 1.
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Sample size: Sample sizes were estimated from the most related
studies for power = 0.80, using effect size Cohen’s d (G*Power
3.1.) with 2-tailed α = 0.05. From a related study on biological changes (6), following large volume liposuction, insulin decreased from 14.9 (mIU/ml) ± 6.5 SD pre-surgery to 7.2 ± 3.2,
4 months post-surgery. Based on this, d = 1.37, and the minimum sample size n= 7 would be needed. From a related study[46]
on psychological changes, the Body Areas Satisfaction Scale
(BASS) scores improved from 3.15 ± 0.64 SD to 3.50 ± 0.61, d=
1.19, and minimum sample size n = 9. Hence, nine subjects were
considered adequate.
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Statistics: Repeated measures ANOVA was performed over the
four time periods. The ANOVA was checked for sphericity, and
the degrees of freedom were adjusted when appropriate. When
the overall F was significant (p < .05), post-hoc paired tests were
performed. Two tailed p values < .05 were considered significant, and p values ranging from .05 to .08 were considered to
be a trend. Means and standard deviations (SD) are used in the
text and tables; means and standard errors (SEM) are used in
the figures. Missing data were interpolated as follows: When the
baseline data was missing, it was not interpolated, and thus the
data for that subject was not used. When the missing data were
between two known values, the average was used for interpolation. If the data was missing from week 12, or from both week 4
and week 12, the last observation carried forward (LOCF) method was used. There were missing data for waist circumference
and body fat measurements, and for BDD, Zung, and BSQ questionnaires, which represented 18% of the total number of possible data for those variables. None of the hormone or glucose
values were missing. SPSS (IBM SPSS, Chicago, IL) was used
to analyze the data.
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Figure 1: a) Body weight (n = 9) decreased significantly between all
time points (F3,24 = 20.2, p < .001; post hoc, all p’s < .03) following
liposuction.
b) Body fat decreased significantly (F3,24 = 13.0, p < .001) from preop
baseline to wk 1, 4, and 12 (post hoc, all p ‘s < .01).
c) Waist circumference decreased significantly between all time points
(F3,24 = 44.5, p < .001; post hoc, all p’s < .03).
d) BMI decreased significantly (F3,24 = 4.3, p = .02) from baseline to wk
1 and to wk 4 as well as wk 1 to wk 4 (post hoc, p < .03). A trend was
shown from baseline to wk 12 (post hoc, p = .06).
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Figure 2: a) Glucose did not change significantly (F3,24 = 0.2, p = 0.89).

b) Leptin decreased significantly (F3,24 = 4.1, p = 0.02) from baseline to
wk 1(post hoc, p = .01), and a trend from baseline to wk 4 and to wk 12
(post hoc, p = .08 and p = .08, respectively).
c) Ghrelin did not change significantly (F3,24 = 1.7, p = .19), but it
showed a trend to decrease from wk 1 to 12 (post hoc, p = .06).
d) Insulin decreased significantly from wk 1 to 12 (F3,24 = 1.4, p = 0.27;
post hoc, p = .049).
e) Insulin resistance (HOMA) did not change significantly (F3,24 = 1.16,
p = 0.35).

Psychological Measures: Body Shape Questionnaire (BSQ)
scores improved significantly (F3,18 = 6.4, p = 0.004) from baseline to wk 4 and baseline to wk 12 (post hoc, p = .002 and
p = .03, respectively) (Figure 3a). Body Dysmorphic Disorder
scores (BDDE-SR) and Zung depression scores (ZDS) did not
change significantly (F3,18 = 2.4, p = 0.1 and F3,18 = 1.5, p = 0.24,
respectively) (Figure 3b,c; Table 2). When repeated measures
ANOVA for BSQ scores were performed with weight change or
fat removal as covariates, the results were no longer significant,
and both covariates were not significant predictors on their own.
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change as a covariate in the repeated measures ANOVA. The
previous changes in insulin and leptin levels were no longer significant. When the amount of fat removed was entered as a covariate, the hormonal changes in leptin and insulin were also no
longer significant. Furthermore, the covariates (weight change
and fat removal) were not significant predictors on their own.
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Glucose and Hormones: Fasting glucose levels (F3,24 = 0.2, p =
0.89) and insulin resistance (HOMA) (F3,24 = 1.16, p = 0.35) did
not change significantly over time (Figure 2a,e). Insulin levels
decreased significantly from wk 1 to wk 12 (F3,24 = 1.4, p = 0.27;
post hoc, p = .049) (Figure 2d). Changes between baseline and
wk 1 in body fat correlated positively with changes in insulin
(r = 0.7, p = .03) and inversely with changes in ghrelin (r = -0.8,
p = .02). Furthermore, changes in waist circumference between
baseline and wk 1 correlated with changes in insulin (r = 0.9;
p = .01), changes in leptin (r = 0.9; p = .004), and changes in glucose (r = 0.8; p = .05). There was an overall significant decrease
in leptin levels (F3,24 = 4.1, p = 0.02) (Figure 2b). Post hoc tests
revealed significant differences from baseline to wk 1 (p = .01),
and trends from baseline to wk 4 (p = .08) and baseline to wk 12
(p =. 08). Ghrelin levels did not change significantly (F3,24 = 1.7,
p = .19), but showed a trend to decrease from wk 1 to wk 12 (p
=. 06) (Figure 2c). Ghrelin and leptin correlated inversely with
each other at baseline (r = -0.73, p = .03) and at wk 1(r = - 0.79,
p = .01).
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as covariates, the significance was lost. This suggests that both
weight change and amount of fat removed had an influence on
leptin and insulin levels although the covariates did not influence the hormone levels significantly on their own.
Results from other studies indicate some similarities
and differences with the present results. A study on overweight
(BMI 27-30, age 39.4 ± 6.8 SD) women who underwent liposuction of large volumes of fat revealed that they had significant
decreases four months postoperatively in fasting plasma insulin,
insulin resistance, and body weight and fat mass, but no significant changes in glucose or leptin[6]. Giugliano et al. found
that six months post liposuction of large volumes of fat, insulin
resistance (HOMA) was significantly reduced in obese and normal-weight women, which correlated with the amount of fat removed[7]. Robles-Cervantes et al. reported that three weeks post
liposuction of large volumes of fat, 15 non-obese women had
significant reductions in glucose and cholesterol, with increases in insulin secretion, whereas insulin resistance (HOMA-IR)
remained unaltered[8]. Klein et al., separated women into two
groups, those with type 2 diabetes (n = 7; age, 52 ± 3) and those
with normal glucose tolerance (n = 8; age = 42 ± 3) and did not
find that liposuction altered plasma glucose, insulin, or insulin
resistance significantly 10-12 weeks after surgery[9]. However,
a number of plasma collections were made at 10 weeks, which
may be too short a time period to observe changes in insulin.
D’Andrea et al. studied metabolic changes following
liposuction of large volumes of fat in 123 healthy women with
grade 1 obesity[47]. They found that 90 days post-operatively,
there were significant decreases in fasting plasma insulin, 2-h
plasma glucose, insulin resistance, and plasma leptin, and that
each factor was correlated with a decrease in fat mass and waistto-hip ratio. These authors also found an improvement in oxidative and non-oxidative glucose metabolism, as well as lipid oxidation, which they suggested as the reasons for improved insulin
sensitivity. It is possible that we did not find an improvement in
insulin resistance in our study due to the relatively large variance
in insulin levels in our subjects at preoperative baseline.
We found that the largest change in the appetite-related hormones leptin and ghrelin occurred at wk 1, and that the
decrease in fat at wk 1 correlated both with leptin (positively)
and ghrelin (inversely). This is consistent with previous findings that body fat correlates positively with leptin and negatively
with ghrelin[15]. Our study was the first to look at ghrelin levels
following liposuction of large volumes of fat in humans, and we
found no significant changes.
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Figure 3: a) Body Shape Questionnaire scores declined significantly

(F3,18 = 6.4, p = 0.004) from baseline to wk 4 (post hoc, p = .002), and
to wk 12 (post hoc, p = .03).
b) Body Dysmorphic Disorder Examination Self-Report (BDDE-SR)
scores did not change significantly (F3,18 = 2.4, p = 0.1).
c) Zung depression scores did not change significantly (F3,18 = 1.5, p =
0.24).

Table 2: Psychological Measures at Baseline and Postop wk 1,
4, 12 (mean ± SD)
Baseline
BSQ

wk 1

wk 4

wk 12

120.4 ± 40.3 110.5 ± 43.1 96.75 ± 34.3 92.1 ± 43.3

BDDE-SR 82.1 ± 50.2

71.4 ± 39.3

56.9 ± 27.6

51.1 ± 36.5

ZDS

35.3 ± 8.2

32.6 ± 11.1

33.1 ± 12.3

33.6 ± 10.3

Psychological Effects
Liposuction of large volumes of fat led to lower scores
in BSQ at wk 4 and wk 12 post-surgery, reflecting improvement
in body image. Commonly, body image improves with weight
loss[33-39]. Roughan et al. showed significant improvements in
body image when women lost an average of 2.8 kg over 10
weeks and another 1 kg at 2 year follow-up[33]. In a study by
Foster et al., body image improved overall following a 48-week
weight-loss program[35]. However, from week 24 to 48, participants experienced a small weight gain, which was associated
with a small, but significant worsening in body image. Other
recent studies also showed that weight loss was associated with
body image improvement[36-38]. In our study, after controlling for

BSQ, Body Shape Questionnaire
BDDE-SR, Body Dysmorphic Disorder Examination Self-Report
ZDS, Zung Self-Rating Depression Scale

Discussion
The results showed that liposuction of large volumes
of fat led to a significant decrease in plasma leptin levels from
baseline to wk 1, and a significant decrease in plasma insulin
from wk 1 to wk 12, although plasma glucose, insulin resistance (HOMA), and plasma ghrelin did not change significantly.
When weight change and amount of fat removed were entered
Geliebter, A., et al
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weight change and amount of fat removed, we found that both
had a partial influence on body dissatisfaction but were not significant predictors on their own.
We did not observe a change in depression scores,
which may in part be due to the absence of high baseline scores,
which would reflect clinical depression. The lack of change in
depression scores is consistent with a postsurgical study for
breast reduction[24], in which scores of depression and anxiety
did not change[24]. Similarly, following a variety of cosmetic surgeries, negative thoughts, quality of life, and depression did not
change at nine months[23].
In our study, scores reflecting the degree of BDDE-SR
also did not change significantly. In a review by Gipson et al.
on various types of cosmetic surgery (rhinoplasty, breast reduction or enlargement, blepharoplasty, and hair transplants), BDD
did not improve post-surgery[29]. Furthermore, in a prospective
rhinoplasty study, those who presented with mild BDD pre-surgery still had BDD five years post-surgery[48]. Similarly, in one
cosmetic surgery study on seven patients with BDD, six presented with BDD five years postoperatively[31]. In contrast in another study, women undergoing a variety of cosmetic procedures
showed decreased BDDE-SR scores six months postoperatively[30]. It is possible that this decrease was due to the women being
instructed to answer the BDDE-SR, specifically in reference to
the feature to be altered rather than the feature that most distressed them, which is the standard protocol[30]. Results in the
present study showed that liposuction, similar to other cosmetic
surgeries, did not improve BDDE-SR.
Limitations of this study include a relatively small number of participants, although the power calculation suggested the
number would be adequate, and the lack of a control group.
In conclusion, this was the first study to examine both
physiological and psychological effects of liposuction of large
volumes of fat. We found that liposuction in overweight and
obese women significantly reduced body weight, BMI, waist
circumference, body fat, and plasma leptin and insulin levels.
However, it did not significantly change glucose or ghrelin concentrations. Moreover, changes in body fat correlated with concurrent changes in levels of the adipose-related hormones, insulin, and ghrelin from baseline to wk 1. Furthermore, changes in
waist circumference correlated with concurrent changes in levels of the adipose-related hormones, insulin and leptin, as well
as glucose from baseline to wk 1. Liposuction of large volumes
of fat also led to improvement in body image. Thus, liposuction
led to several positive body composition, hormonal, and psychological changes.
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